Skip to main content
NovartisOffice expansion

Novartis continues to cut jobs in Switzerland

What happened

Novartis plans to move part of its biologics production activities from Kleinbasel to its campus in Basel by the end of 2027.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

Novartis announced on September 2 that it would cease the production of biologics in Kleinbasel by the end of 2027. Part of the activities is to be moved to the Novartis Campus in Basel, and the majority of production will be relocated abroad in the future. For Syna, it is clear: The reduction of production capacities and jobs in Switzerland must not simply be accepted. "Enough with expanding profit margins, we need pharmaceutical production in Switzerland," says Astrid Beigel, Head of Industry at Syna.

syna.ch/aktuell/novartis-baut-weiter-stellen-in-der-schweiz-ab-syna-f...Read the full source

Extracted by Autobound

From the Signal API record
Event
Office expansion

What this signalsA larger office often means more people who need tools and services.

Takes effect
Dec 31, 2027
Location
Basel, Basel-Stadt, Switzerland

More office expansion signals at other companies

The full record

From the Signal API record

Extraction

Confidence
90%
Detected
Sep 7, 2026
signal_type
news
signal_subtype
expands_offices_in

Use this data

Get every office expansion signal for Novartis and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Novartis this week?”

  2. Send it to your own tools

    The Signal API returns office expansion signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/771e9dea-4369-fb59-dfdc-fd3e7afd141c returns this record as JSON. POST /v1/companies/enrich returns every signal for novartis.com.

{
  "signal_id": "771e9dea-4369-fb59-dfdc-fd3e7afd141c",
  "signal_type": "news",
  "signal_subtype": "expands_offices_in",
  "detected_at": "2026-09-07T11:21:00+00:00",
  "company": {
    "name": "Novartis",
    "domain": "novartis.com"
  },
  "data": {
    "url": "https://syna.ch/aktuell/novartis-baut-weiter-stellen-in-der-schweiz-ab-syna-fordert-erhalt-der-arbeitsplaetze",
    "title": "Novartis continues to cut jobs in Switzerland – Syna demands preservation of jobs",
    "excerpt": "Novartis announced on September 2 that it would cease the production of biologics in Kleinbasel by the end of 2027. Part of the activities is to be moved to the Novartis Campus in Basel, and the majority of production will be relocated abroad in the future. For Syna, it is clear: The reduction of production capacities and jobs in Switzerland must not simply be accepted. \"Enough with expanding profit margins, we need pharmaceutical production in Switzerland,\" says Astrid Beigel, Head of Industry at Syna.",
    "summary": "Novartis plans to move part of its biologics production activities from Kleinbasel to its campus in Basel by the end of 2027.",
    "location": "Basel, Switzerland",
    "planning": true,
    "image_url": "https://syna.ch/images/easyblog_articles/9012/img_large_Pharmaindustrie0_20260203-152302_1.jpeg",
    "confidence": 0.9,
    "published_at": "2026-09-07T11:21:00Z",
    "location_data": [
      {
        "city": "Basel",
        "state": "Basel-Stadt",
        "region": "Western Europe",
        "country": "Switzerland",
        "continent": "Europe",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2027-12-31",
    "article_sentence": "Part of the activities is to be moved to the Novartis Campus in Basel, and the majority of production will be relocated abroad in the future."
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.